These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25788239)

  • 1. Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections.
    Friend DR
    Drug Deliv Transl Res; 2011 Jun; 1(3):185-93. PubMed ID: 25788239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.
    Friend DR
    Expert Opin Drug Deliv; 2012 Apr; 9(4):417-27. PubMed ID: 22385316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.
    Thurman AR; Clark MR; Hurlburt JA; Doncel GF
    Int J Womens Health; 2013 Oct; 5():695-708. PubMed ID: 24174884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide.
    Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD
    Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir.
    Johnson TJ; Gupta KM; Fabian J; Albright TH; Kiser PF
    Eur J Pharm Sci; 2010 Feb; 39(4):203-12. PubMed ID: 19958831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical development of microbicide drug products.
    Friend DR
    Pharm Dev Technol; 2010 Dec; 15(6):562-81. PubMed ID: 20017601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a multi-layered vaginal tablet containing dapivirine, levonorgestrel and acyclovir for use as a multipurpose prevention technology.
    McConville C; Major I; Devlin B; Brimer A
    Eur J Pharm Biopharm; 2016 Jul; 104():171-9. PubMed ID: 27163243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model.
    Smith JM; Moss JA; Srinivasan P; Butkyavichene I; Gunawardana M; Fanter R; Miller CS; Sanchez D; Yang F; Ellis S; Zhang J; Marzinke MA; Hendrix CW; Kapoor A; Baum MM
    PLoS One; 2017; 12(10):e0185946. PubMed ID: 28982161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multipurpose prevention technologies: products in development.
    Friend DR; Clark JT; Kiser PF; Clark MR
    Antiviral Res; 2013 Dec; 100 Suppl():S39-47. PubMed ID: 24188708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Methods for Evaluating Drug Release of Vaginal Ring Formulations-A Critical Review.
    Tietz K; Klein S
    Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31623277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-releasing vaginal rings for HIV/STI and pregnancy prevention: a review of recent advances and clinical applications.
    Palanee-Phillips T; Baum MM; Moss JA; Clark MR; Nuttall J; Romano JW
    Expert Opin Drug Deliv; 2022 Jan; 19(1):47-58. PubMed ID: 34958283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women.
    Nel A; Smythe S; Young K; Malcolm K; McCoy C; Rosenberg Z; Romano J
    J Acquir Immune Defic Syndr; 2009 Aug; 51(4):416-23. PubMed ID: 19623693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meaning-making matters in product design: users' sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings.
    Rosen RK; van den Berg JJ; Vargas SE; Senocak N; Shaw JG; Buckheit RW; Smith KA; Guthrie KM
    Contraception; 2015 Dec; 92(6):596-601. PubMed ID: 26276246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies.
    Friend DR; Doncel GF
    Antiviral Res; 2010 Dec; 88 Suppl 1():S47-54. PubMed ID: 21109068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on multipurpose prevention technologies for the prevention of HIV transmission and pregnancy.
    Friend DR
    Expert Opin Drug Deliv; 2016; 13(4):533-45. PubMed ID: 26742698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Hydroxychloroquine-Loaded Polyurethane Intravaginal Rings on Lactobacilli.
    Traore YL; Chen Y; Bernier AM; Ho EA
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7680-6. PubMed ID: 26416871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compartmental transport model of microbicide delivery by an intravaginal ring.
    Geonnotti AR; Katz DF
    J Pharm Sci; 2010 Aug; 99(8):3514-21. PubMed ID: 20222027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future strategies in microbicide development.
    Rosenberg ZF; Devlin B
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug; 26(4):503-13. PubMed ID: 22406260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial biofilms on the surface of intravaginal rings worn in non-human primates.
    Gunawardana M; Moss JA; Smith TJ; Kennedy S; Kopin E; Nguyen C; Malone AM; Rabe L; Schaudinn C; Webster P; Srinivasan P; Sweeney ED; Smith JM; Baum MM
    J Med Microbiol; 2011 Jun; 60(Pt 6):828-837. PubMed ID: 21393449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.